Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Midatech Pharma plc
  6. Summary
    MTPH   GB00BKT14T00

MIDATECH PHARMA PLC

(MTPH)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
26.25(c) 26.25(c) 25.5(c) 25.5(c) 27.25(c) Last
167 938 218 048 216 220 153 909 1 594 264 Volume
+0.96% 0.00% -2.86% 0.00% +6.86% Change
More quotes
Estimated financial data (e)
Sales 2019 0,67 M 0,93 M 0,93 M
Net income 2019 -10,1 M -13,9 M -13,9 M
Net cash position 2019 3,94 M 5,41 M 5,41 M
P/E ratio 2019 -1,02x
Yield 2019 -
Sales 2020 0,34 M 0,47 M 0,47 M
Net income 2020 -22,2 M -30,5 M -30,5 M
Net cash position 2020 7,21 M 9,91 M 9,91 M
P/E ratio 2020 -0,51x
Yield 2020 -
Capitalization 26,8 M 36,9 M 36,9 M
EV / Sales 2019 13,7x
EV / Sales 2020 27,7x
Nbr of Employees 18
Free-Float 87,0%
More Financials
Company
Midatech Pharma PLC is a research and development biopharmaceutical company that is focused on commercializing and developing products in oncology and other therapeutic areas. The Company operates through Pipeline Research and Development segment. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Company develops chemo... 
Sector
Biotechnology & Medical Research
Calendar
09/17 | 02:00amEarnings Release
More about the company
All news about MIDATECH PHARMA PLC
09/17FTSE 100 Closes Friday Down as Markets Remain Under Pressure
DJ
09/17MIDATECH PHARMA : (“Midatech” or the “Company”) (Form 6-..
PU
09/17FTSE Rises, Weak Retail Sales Could Hamper Sterling's Rise
DJ
08/18MIDATECH PHARMA : Result of 2021 Annual General Meeting (Form 6-K)
PU
07/21MIDATECH PHARMA : welcomes Dr Dmitry Zamoryakhin as Chief Scientific Officer
AQ
07/12Midatech Pharma plc Announces Executive Changes
CI
06/29MIDATECH PHARMA : UK Placing to Raise £10.0 million (Form 6-K)
PU
06/29FTSE 100 Rises 0.3% as Construction Stocks Gain
DJ
06/29MIDATECH PHARMA : Corporate Overview
PU
06/29FTSE 100 Tipped to Open Lower After Mixed Asia, U.S. Sessions
DJ
06/17SECTOR UPDATE : Health Care Stocks Add to Afternoon Gains
MT
06/17SECTOR UPDATE : Health Care Stocks Maintaining Modest Thursday Advance
MT
06/17Wall Street Set for Losses on Fed-Induced Weakness
MT
06/17MIDATECH PHARMA : Breakthrough data on the successful encapsulation of a biologi..
PU
06/17Midatech Pharma PLC Announces Breakthrough Data on the Successful Encapsulati..
CI
More news
News in other languages on MIDATECH PHARMA PLC

- No features available -

More news
Chart MIDATECH PHARMA PLC
Duration : Period :
Midatech Pharma plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MIDATECH PHARMA PLC
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 0,27 
Average target price
Spread / Average Target -
Managers and Directors
Stephen Anthony Stamp Director, Chief Executive & Financial Officer
Rolf Stahel Non-Executive Chairman
Steve Damment Executive Vice President-Research & Development
Dmitry Zamoryakhin Chief Scientific Officer
Sijmen de Vries Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MIDATECH PHARMA PLC2.83%37
BIONTECH SE340.60%90 003
GILEAD SCIENCES, INC.22.91%89 434
REGENERON PHARMACEUTICALS34.93%67 910
WUXI APPTEC CO., LTD.35.75%65 728
VERTEX PHARMACEUTICALS-20.33%48 539